Pediatrics
Showing 661-680 of 1,545 Results
-
Siva Kasinathan
Instructor, Pediatrics - Rheumatology
BioSiva Kasinathan, MD, PhD is a physician-scientist and Instructor of Pediatric Rheumatology at the Stanford University School of Medicine and Lucile Packard Children's Hospital. In addition to caring for children and young adults with rheumatic diseases in his clinical practice, Siva conducts research to advance the understanding of mechanisms of autoimmunity and autoinflammation.
Siva holds an MD and PhD in Molecular and Cell Biology from the University of Washington, where he developed several high-throughput methods for epigenome profiling and contributed new insights in chromatin biology and gene regulation. During his clinical training in pediatrics and rheumatology at Stanford, Siva pioneered approaches for single-molecule analysis of genetic variation, DNA methylation, and chromatin structure, and established a longitudinal rheumatic disease cohort and biorepository.
Siva’s current research bridges genomics and immunology with a focus on developing and applying sensitive technologies to unravel the genetic and molecular underpinnings of lupus, arthritis, and other immune-mediated diseases. As a physician-scientist, Siva is committed to translating fundamental discoveries into precision therapies and biomarkers to improve outcomes for patients with rheumatic diseases. -
Aanchal Preet Kaur
Postdoctoral Scholar, Hematology-Oncology
BioDr. Aanchal Preet Kaur is a post-doctoral fellow in the Ramakrishna lab interested in understanding the role of myeloid cells in driving immunosuppression and resistance to CAR T cell therapies in pediatric patients with diffuse midline glioma. Her work involves developing organoid models to study the interaction of myeloid cells and CAR T cells and further employ these models to validate targets identified in patient single cell sequencing data using CRISPR technology.
Dr. Aanchal Preet Kaur received her PhD in Oncology at the University of Nottingham, United Kingdom where she focused on developing dendritic cell vaccines for melanoma. In her earlier post-doctoral work at Providence Cancer Institute with Dr. Michael Gough, she developed spheroid models to study the impact of radiation therapy on immune cell-cancer cell interactions. -
Mark A. Kay, M.D., Ph.D.
Dennis Farrey Family Professor of Pediatrics, and Professor of Genetics
Current Research and Scholarly InterestsMark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.
-
John Kerner
Professor of Pediatrics (Gastroenterology), Emeritus
Current Research and Scholarly InterestsI am interested in pediatric nutritional support and have experience evaluating new enteral and parenteral products especially for the neonate (I studied a "new" I.V. fat product for Abbott; I participated in a multicenter trial of a formula with fish oil in it for neonates with Mead Johnson and a multicenter trial of a new human milk fortifier for Wyeth).
-
Kian Keyashian
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioThe management of inflammatory bowel disease continues to evolve, with the introduction of biologic and small molecule therapies and new goals of treatment, with an emphasis on healing the bowel. My career goal since my graduation from IBD fellowship in 2012 has been to improve the outcomes and quality of life of patients with inflammatory bowel disease. In line with these goals, my research has focused investigating new noninvasive diagnostic test, finding factors early in the disease course that might predict a more aggressive disease course and need for different therapies, and investigating new promising effective medications with less side effects.
